Post by Myriad Genetics

112,222 followers

#ASBrS2026 attendees: Join Myriad Oncology tonight for an engaging evening symposium exploring the evolving role of tumor-informed molecular residual disease (MRD) testing in the treatment of breast cancer. A multidisciplinary panel discussion will address current evidence, technical and practical considerations, and future directions for the incorporation of MRD testing into surgical and postoperative care pathways. š‘šžš š¢š¬š­šžš« š§šØš°, š¬šžššš­š¢š§š  š¢š¬ š„š¢š¦š¢š­šžš! https://brnw.ch/21x27bU For more information, visit ššØšØš­š” šŸšŸšŸ. #BreastCancer #PrecisionMedicine #GeneticInsights #MRD

Post content